Furthermore, Epac promotes cell proliferation in ovarian cancer, both in vitro and in vivo, by activating PI3K/Akt/Cyclin D1/CDK4 pathway [58]. The gene discussed is RAPGEF4; the disease is ovarian carcinoma.